Corium Innovations, Inc.
Clinical trials sponsored by Corium Innovations, Inc., explained in plain language.
-
Generic selegiline patch put to the test in healthy volunteers
Knowledge-focused CompletedThis study compares a new generic selegiline skin patch to the brand-name EMSAM® patch in 92 healthy adults. Researchers measure how much drug enters the bloodstream and how well the patch sticks to the skin over 24 hours. The goal is to see if the generic version works just as w…
Phase: PHASE1 • Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 07:00 UTC
-
Generic depression patch tested against brand in small study
Knowledge-focused CompletedThis study tested whether a generic selegiline skin patch works the same as the brand-name EMSAM patch. Twelve healthy adults wore both patches to measure how much drug got into their blood and to check for skin irritation. The goal was to see if the generic version is a safe and…
Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Patch vs. pill: new ozanimod skin patch tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new way to deliver the drug ozanimod using a skin patch instead of oral capsules. 24 healthy adults either took one capsule or wore a patch for 7 days. Researchers measured drug levels in the blood and checked for skin reactions to see if the patch works well …
Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC